2026. Off-label use of tirzepatide: analysis of sarcopenia risk in individuals without clinical indication. Revista Eletrônica Acervo Médico. 23, (Sep. 2026), e25022. DOI:https://doi.org/10.25248/reamed.e25022.2026.